Home > Healthcare > Medical Devices > Diagnostic Devices > Liver Cancer Diagnostics Market

Liver Cancer Diagnostics Market Share

Report ID: GMI6100
Published Date: Jun 2023
Report Format: PDF

Download Free Sample

Liver Cancer Diagnostics Market Share

Some of the major players operating in the liver cancer diagnostics market are

AB SCIEX
Agilent Technologies Inc.
Becton
Dickinson & Company
Biocare Medical, LLC
bioMérieux SA
Bio-Rad Laboratories, Inc
Danaher Corporation
Epigenomics Ag
F. Hoffmann-La Roche Ltd.
General Electric Company
Hoffmann La-Roche Ltd.
Hologic, Inc.
Johnson & Johnson
Koninklijke Philips N.V.
Qiagen N.V.
Seimens Healthineers
Sysmex Corporation
Thermo Fisher Scientific, Inc.

These leading market players are implementing advanced technologies to cater to the large unmet needs of the consumers. These players focus on strategic partnerships, new product launch & commercialization for market expansion.

Authors: Mariam Faizullabhoy , Shishanka Wangnoo

Frequently Asked Questions (FAQ) :

The market size of liver cancer diagnostics was worth more than USD 10.5 billion in 2022 and is estimated to reach USD 20.7 billion by 2032 driven by the high prevalence of liver cancer coupled with the rising awareness and screening programs.

The laboratory test segment accounted for more than 32% of the liver cancer diagnostics market share in 2022 and is set to record substantial growth through 2032 owing to the benefits of early detection of liver cancer through lab tests to enable timely intervention and treatment.

North America market for liver cancer diagnostics generated USD 4.4 billion in 2022 and is poised to grow at a notable CAGR from 2023 to 2032 owing to the increasing technological advancement in cancer diagnostic techniques and favorable R&D initiatives.

Some of the major liver cancer diagnostics business players include AB SCIEX, Agilent Technologies Inc., Becton, Dickinson & Company, Biocare Medical, LLC, bioM